A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, blood platelet disease, hematologic disorder, neonatal thrombocytopenia, thrombocytopenia	Recruiting	Phase 3	2026-09-25		NCT06449651

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Research & Development, LLC	188

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre hospitalier universitaire vaudois CHUV	Lausanne	Switzerland	5
CHRU Lille	Lille	France	10
Fakultna nemocnica s poliklinikou Nove Zamky	Nové Zámky	Slovakia	6
Fondazione Policlinico Universitario A Gemelli IRCCS	Rome	Italy	1
Haukeland University Hospital	Bergen	Norway	11
Hopital trousseau- APHP	Paris	France	2
Hosp. Virgen Del Rocio	Seville	Spain	37
Hospital Das Clinicas Da Faculdade De Medicina Da USP	São Paulo	Brazil	4
IDOR - Regional Rio de Janeiro	Rio de Janeiro	Brazil	4
Instituto de Medicina Integral Professor Fernando Figueira	Recife	Brazil	2
Karolinska Universitetssjukhuset Huddinge	Stockholm	Sweden	1
Mangiagalli Clinic IRCCS Ca Granda Foundation Ospedale Maggiore Policlinico	Milan	Italy	2
Oslo University Hospital HF Ulleval sykehus	Oslo	Norway	1
Semmelweis Egyetem	Budapest	Hungary	21
Sheba Medical Center	Ramat Gan	Israel	11
St. Olavs Hospital	Trondheim	Norway	17
Universitair Ziekenhuis Leuven	Leuven	Belgium	37
Universitetssykehuset Nord-Norge HF	Tromsø	Norway	1
Univerzitetni klinicni center Ljubljana	Ljubljana	Slovenia	3
Univerzitna nemocnica L. Pasteura Kosice	Košice	Slovakia	2
Univerzitná nemocnica Martin	Martin	Slovakia	1

Clinical trials